E74 Like ETS Transcription Factor 3 is a Negative Regulator of Pathogenic Lamina Propria T Helper 17.1 Cells in Murine Colitis

References

• Ahmad SF, Nadeem A, Ansari MA, Bakheet SA, Alshammari MA, Attia SM. 2018. The PPARdelta agonist GW0742 restores neuroimmune function by regulating Tim-3 and Th17/Treg-related signaling in the BTBR autistic mouse model. Neurochem Int. 120:251–61.
   PubMedGoogle Scholar
• Al-Harbi NO, Nadeem A, Al-Harbi MM, Ansari MA, AlSharari SD, Bahashwan SA, Attia SM, Al-Hosaini KA, Al Hoshani AR, Ahmad SF, et al. 2016. Airway oxidative stress causes vascular and hepatic inflammation via upregulation of IL-17A in a murine model of allergic asthma. Int Immunopharmacol. 34:173–82.
   PubMed Web of Science ®Google Scholar
• Andreoli JM, Jang SI, Chung E, Coticchia CM, Steinert PM, Markova NG. 1997. The expression of a novel, epithelium-specific ets transcription factor is restricted to the most differentiated layers in the epidermis. Nucleic Acids Res. 25(21):4287–95.
   PubMedGoogle Scholar
• Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S. 2009. Human Th17 cells: are they different from murine Th17 cells? Eur J Immunol. 39(3):637–40.
   PubMed Web of Science ®Google Scholar
• Arger NK, Machiraju S, Allen IE, Woodruff PG, Koth LL. 2020. T-Bet expression in peripheral Th17.0 cells is associated with pulmonary function changes in sarcoidosis. Front Immunol. 11:1129.
   PubMedGoogle Scholar
• Bailey SR, Nelson MH, Himes RA, Li Z, Mehrotra S, Paulos CM. 2014. Th17 cells in cancer: the ultimate identity crisis. Front Immunol. 5:276.
   PubMed Web of Science ®Google Scholar
• Bakheet SA, Ansari MA, Nadeem A, Attia SM, Alhoshani AR, Gul G, Al-Qahtani QH, Albekairi NA, Ibrahim KE, Ahmad SF, et al. 2019. CXCR3 antagonist AMG487 suppresses rheumatoid arthritis pathogenesis and progression by shifting the Th17/Treg cell balance. Cell Signal. 64:109395.
   PubMed Web of Science ®Google Scholar
• Brembeck FH, Opitz OG, Libermann TA, Rustgi AK. 2000. Dual function of the epithelial specific ets transcription factor, ELF3, in modulating differentiation. Oncogene. 19(15):1941–49.
   PubMedGoogle Scholar
• Cooper CD, Newman JA, Gileadi O. 2014. Recent advances in the structural molecular biology of Ets transcription factors: interactions, interfaces and inhibition. Biochem Soc Trans. 42(1):130–38.
   PubMedGoogle Scholar
• Davila E, Kolls J. 2010. A “Toll” for Th17 cell expansion. J Leukoc Biol. 88(1):5–7.
   PubMedGoogle Scholar
• Giuffrida P, Di Sabatino A. 2020. Targeting T cells in inflammatory bowel disease. Pharmacol Res. 159:105040.
   PubMed Web of Science ®Google Scholar
• Grall FT, Prall WC, Wei W, Gu X, Cho JY, Choy BK, Zerbini LF, Inan MS, Goldring SR, Gravallese EM, et al. 2005. The Ets transcription factor ESE-1 mediates induction of the COX-2 gene by LPS in monocytes. Febs J. 272(7):1676–87.
   PubMed Web of Science ®Google Scholar
• Guo Y, Bai AP. 2019. Plasticity of Th17 cells contributes to crohn’s disease. Gastroenterology. 157(6):1689.
   PubMedGoogle Scholar
• Harbour SN, Maynard CL, Zindl CL, Schoeb TR, Weaver CT. 2015. Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis. Proc Natl Acad Sci USA. 112(22):7061–66.
   PubMed Web of Science ®Google Scholar
• Hollenhorst PC, McIntosh LP, Graves BJ. 2011. Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem. 80(1):437–71.
   PubMedGoogle Scholar
• Hou G, Bishu S. 2020. Th17 Cells in inflammatory bowel disease: an update for the clinician. Inflamm Bowel Dis. 26(5):653–61.
   PubMed Web of Science ®Google Scholar
• Hou L, Yuki K. 2022. CCR6 and CXCR6 identify the Th17 cells with cytotoxicity in experimental autoimmune encephalomyelitis. Front Immunol. 13:819224.
   PubMed Web of Science ®Google Scholar
• Kamali AN, Noorbakhsh SM, Hamedifar H, Jadidi-Niaragh F, Yazdani R, Bautista JM, Azizi G. 2019. A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders. Mol Immunol. 105:107–15.
   PubMed Web of Science ®Google Scholar
• Lexberg MH, Taubner A, Albrecht I, Lepenies I, Richter A, Kamradt T, Radbruch A, Chang H-D. 2010. IFN-γ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells. Eur J Immunol. 40(11):3017–27.
   PubMed Web of Science ®Google Scholar
• Luk IY, Reehorst CM, Mariadason JM. 2018. ELF3, ELF5, EHF and SPDEF transcription factors in tissue homeostasis and cancer. Molecules. 23(9):2191.
   Google Scholar
• Maeda S, Osaga S, Maeda T, Takeda N, Tamechika SY, Naniwa T, Niimi A. 2019. Circulating Th17.1 cells as candidate for the prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: an exploratory research. PLoS One. 14(11):e0215192.
   PubMed Web of Science ®Google Scholar
• Nadeem A, Ahmad SF, Al-Harbi NO, Attia SM, Bakheet SA, Ibrahim KE, Alqahtani F, Alqinyah M. 2019b. Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice. Behav Brain Res. 364:213–24.
   PubMedGoogle Scholar
• Nadeem A, Ahmad SF, Al-Harbi NO, El-Sherbeeny AM, Alasmari AF, Alanazi WA, Alasmari F, Ibrahim KE, Al-Harbi MM, Bakheet SA, et al. 2020. Bruton’s tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells. Int Immunopharmacol. 80:106215.
   PubMed Web of Science ®Google Scholar
• Nadeem A, Ahmad SF, Attia SM, Al-Ayadhi LY, Bakheet SA, Al-Harbi NO. 2019a. Oxidative and inflammatory mediators are upregulated in neutrophils of autistic children: role of IL-17A receptor signaling. Prog Neuropsychopharmacol Biol Psychiatry. 90:204–11.
   PubMedGoogle Scholar
• Park JH, Jeong SY, Choi AJ, Kim SJ. 2015. Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-κB1. Immunol Lett. 165(1):10–19.
   PubMed Web of Science ®Google Scholar
• Reynolds JM, Martinez GJ, Chung Y, Dong C. 2012. Toll-Like receptor 4 signaling in T cells promotes autoimmune inflammation. Proc Natl Acad Sci USA. 109(32):13064–69.
   PubMed Web of Science ®Google Scholar
• Saravanarajan K, Douglas AR, Ismail MS, Omorogbe J, Semenov S, Muphy G, O’-Riordan F, McNamara D, Nakagome S. 2020. Genomic profiling of intestinal T-cell receptor repertoires in inflammatory bowel disease. Genes Immun. 21(2):109–18.
   PubMedGoogle Scholar
• Soukou S, Huber S, Krebs CF. 2021. T cell plasticity in renal autoimmune disease. Cell Tissue Res. 385(2):323–33.
   PubMedGoogle Scholar
• van Hamburg JP, Tas SW, van Hamburg JP. 2018. Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis. J Autoimmun. 87:69–81.
   PubMed Web of Science ®Google Scholar
• van Langelaar J, van der Vuurst de Vries RM, Janssen M, Wierenga-Wolf AF, Spilt IM, Siepman TA, Dankers W, Verjans GMGM, de Vries HE, Lubberts E. et al. 2018. T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention. Brain. 141(5):1334–49.
   PubMedGoogle Scholar